Search Results - "Cimbolli, Paola"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
  2. 2

    The case of Giorgia: a systemic cognitive postrationalist intervention by Cimbolli, Paola

    Published in Rivista di psichiatria (01-09-2011)
    “…To describe and to explain a clinical case from a cognitive systemic perspective means to focus on "how" the different data were set in order and organized…”
    Get more information
    Journal Article
  3. 3

    Post-rationalist psychotherapy academy today:research and clinical practice by De Pascale, Adele, Quiñones, Álvaro, Cimbolli, Paola

    Published in Rivista di psichiatria (01-01-2016)
    “…The post-rationalist psychotherapy academy (non-classic cognitive approach) started at the end of the 80's with a series of consistent hypotheses. It is an…”
    Get more information
    Journal Article
  4. 4

    Pilot study on nutritional and eating disorders in children and mood disorders: comorbidity or prodromal traits? by Cimbolli, Paola, Quiñones, Álvaro, Ugarte, Carla, De Pascale, Adele

    Published in Rivista di psichiatria (01-01-2017)
    “…Both children affected by nutritional and eating disorders (ED) and adults with bipolar disorder (BD) display symptoms of deficient emotional self-regulation,…”
    Get more information
    Journal Article
  5. 5

    Antipsychotic drug use: McLean Hospital, 2002 by Centorrino, Franca, Fogarty, Kate V., Sani, Gabriele, Salvatore, Paola, Cimbolli, Paola, Baldessarini, Ross J.

    Published in Human psychopharmacology (01-07-2005)
    “…Objective Major changes in antipsychotic treatment in recent years encouraged a survey of inpatient practice in 2002, compared with earlier samples. Methods…”
    Get full text
    Journal Article
  6. 6

    Aripiprazole: initial clinical experience with 142 hospitalized psychiatric patients by Centorrino, Franca, Fogarty, Kate V, Cimbolli, Paola, Salvatore, Paola, Thompson, Terri-Ann, Sani, Gabriele, Cincotta, Stephanie L, Baldessarini, Ross J

    Published in Journal of psychiatric practice (01-07-2005)
    “…Aripiprazole is the first dopamine D2 receptor partial-agonist approved for treatment of schizophrenia. Its apparently benign adverse-effect profile encourages…”
    Get full text
    Journal Article